Journal: The Cochrane Database of Systematic Reviews

Article Title: Tafenoquine for preventing relapse in people with Plasmodium vivax malaria

doi: 10.1002/14651858.CD010458.pub3

Figure Lengend Snippet: Lacerda 2019

Article Snippet: Random sequence generation (selection bias) , Low risk , Quote: "With the use of a computer‐generated randomisation schedule provided by GlaxoSmithKline, on day 1 eligible participants were randomly assigned, in a 2:1:1 ratio…".

Techniques: Activity Assay, Infection, Sequencing, Selection

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tafenoquine for preventing relapse in people with Plasmodium vivax malaria

doi: 10.1002/14651858.CD010458.pub3

Figure Lengend Snippet: Llanos‐Cuentas 2014

Article Snippet: Random sequence generation (selection bias) , Low risk , Quote: "With the use of a computer‐generated randomisation schedule provided by GlaxoSmithKline, on day 1 eligible participants were randomly assigned, in a 2:1:1 ratio…".

Techniques: Activity Assay, Infection, Sequencing, Selection, Generated

Journal: Trials

Article Title: Statistical analysis plan for the POLAR-RCT: The Prophylactic hypOthermia trial to Lessen trAumatic bRain injury-Randomised Controlled Trial

doi: 10.1186/s13063-018-2610-y

Figure Lengend Snippet: The count of strata incorporated within the block-randomised 1:1 hypothermia / normothermia treatment allocation schedule

Article Snippet: The computer-generated randomised treatment allocation schedule (using Stata version 11 ralloc module http://fmwww.bc.edu/repec/bocode/r/ralloc.ado ) [ ] was stratified by hospital group or pre-hospital paramedic ambulance service with a permuted block scheme.

Techniques: Blocking Assay, Western Blot

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: ACCLAIM/COPD I

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: ACCLAIM/COPD II

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: ACCORD COPD I

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: ACCORD COPD II

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Infection, Comparison, Medications, Concentration Assay, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: ACLIFORM

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Infection, Transplantation Assay, Functional Assay, Comparison, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: ATTAIN

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: AUGMENT COPD

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Infection, Comparison, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: Beier 2013

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: Chanez 2010

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Activity Assay, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: NCT01572792

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Comparison, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: Sliwinski 2010

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Comparison, Sequencing, Selection